Response to "Letter to Editor From Ishaq MU et al: 'Semaglutide Concurrently Improves Vascular and Liver Indices in Patients With Type 2 Diabetes and Fatty Liver Disease'"

Response to "Letter to Editor From Ishaq MU et al: 'Semaglutide Concurrently Improves Vascular and Liver Indices in Patients With Type 2 Diabetes and Fatty Liver Disease'"

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the Endocrine Society 2024-11, Vol.9 (1), p.bvae218
Hauptverfasser: Korakas, Emmanouil, Kountouri, Aikaterini, Pavlidis, George, Oikonomou, Evangelos, Vrentzos, Emmanouil, Michalopoulou, Eleni, Tsigkou, Vasiliki, Katogiannis, Konstantinos, Pliouta, Loukia, Balampanis, Konstantinos, Pililis, Sotirios, Malandris, Konstantinos, Tsapas, Apostolos, Siasos, Gerasimos, Ikonomidis, Ignatios, Lambadiari, Vaia
Format: Artikel
Sprache:eng
Schlagworte:
Letter to the Editor Response
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 1
container_start_page bvae218
container_title Journal of the Endocrine Society
container_volume 9
creator Korakas, Emmanouil
Kountouri, Aikaterini
Pavlidis, George
Oikonomou, Evangelos
Vrentzos, Emmanouil
Michalopoulou, Eleni
Tsigkou, Vasiliki
Katogiannis, Konstantinos
Pliouta, Loukia
Balampanis, Konstantinos
Pililis, Sotirios
Malandris, Konstantinos
Tsapas, Apostolos
Siasos, Gerasimos
Ikonomidis, Ignatios
Lambadiari, Vaia
description
doi_str_mv 10.1210/jendso/bvae218
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11663492</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3148498448</sourcerecordid><originalsourceid>FETCH-LOGICAL-p1122-588dd7661f516f340047dd1cdce4470a5fe88a2e274626abe973b61c119f79f63</originalsourceid><addsrcrecordid>eNpVkUFv1DAQhS0EolXplSMa9VIuSzOO13a4oGrbhZUWgaCFY-SNJ11XiZ3azkr7m_iTpGJB5TRPmve9J80w9hqLd8ixuLgnb1O42OwMcdTP2DEXis-wUvz5E33ETlO6L4oCq1JUQrxkR2WlELVQx-zXN0pD8IkgBzhbU84UH-W1dTlEWMbQwyptzQN8vgXKYLr3cP6denPXjdlZgkXwzRgj-dztYdUPMewowQ-TmrEzEYy3sHa7KXTlrWumlfPw1WQ3AQl-uryFm_1AwOHKmQ3lyfCILE3O-wN45RKZROdnr9iL1nSJTg_zhN0ur28Wn2brLx9Xi8v1bEDkfDbX2lolJbZzlG0pikIoa7GxDQmhCjNvSWvDiSshuZxKK1VuJDaIVauqVpYn7MOf3GHc9DRhPkfT1UN0vYn7OhhX_7_xblvfhV2NKOV0Yj4lvD0kxPAwUsp171JDXWc8hTHVJQotKi2Enqxvnpb9a_n7ovI3gMuW0g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3148498448</pqid></control><display><type>article</type><title>Response to "Letter to Editor From Ishaq MU et al: 'Semaglutide Concurrently Improves Vascular and Liver Indices in Patients With Type 2 Diabetes and Fatty Liver Disease'"</title><source>DOAJ Directory of Open Access Journals</source><source>Oxford Journals Open Access Collection</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Korakas, Emmanouil ; Kountouri, Aikaterini ; Pavlidis, George ; Oikonomou, Evangelos ; Vrentzos, Emmanouil ; Michalopoulou, Eleni ; Tsigkou, Vasiliki ; Katogiannis, Konstantinos ; Pliouta, Loukia ; Balampanis, Konstantinos ; Pililis, Sotirios ; Malandris, Konstantinos ; Tsapas, Apostolos ; Siasos, Gerasimos ; Ikonomidis, Ignatios ; Lambadiari, Vaia</creator><creatorcontrib>Korakas, Emmanouil ; Kountouri, Aikaterini ; Pavlidis, George ; Oikonomou, Evangelos ; Vrentzos, Emmanouil ; Michalopoulou, Eleni ; Tsigkou, Vasiliki ; Katogiannis, Konstantinos ; Pliouta, Loukia ; Balampanis, Konstantinos ; Pililis, Sotirios ; Malandris, Konstantinos ; Tsapas, Apostolos ; Siasos, Gerasimos ; Ikonomidis, Ignatios ; Lambadiari, Vaia</creatorcontrib><identifier>ISSN: 2472-1972</identifier><identifier>EISSN: 2472-1972</identifier><identifier>DOI: 10.1210/jendso/bvae218</identifier><identifier>PMID: 39711847</identifier><language>eng</language><publisher>United States: Oxford University Press</publisher><subject>Letter to the Editor Response</subject><ispartof>Journal of the Endocrine Society, 2024-11, Vol.9 (1), p.bvae218</ispartof><rights>The Author(s) 2024. Published by Oxford University Press on behalf of the Endocrine Society. 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0002-2416-1461 ; 0000-0003-0221-4072 ; 0000-0003-4209-1871 ; 0000-0001-7601-8870 ; 0000-0002-5134-2401 ; 0000-0001-5829-7327 ; 0009-0002-2157-0814 ; 0000-0001-8079-0599 ; 0000-0002-7813-5488 ; 0009-0007-8693-4443 ; 0000-0003-1631-5210 ; 0000-0002-4620-4039 ; 0009-0005-6480-3878 ; 0000-0001-8241-7886</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11663492/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11663492/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39711847$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Korakas, Emmanouil</creatorcontrib><creatorcontrib>Kountouri, Aikaterini</creatorcontrib><creatorcontrib>Pavlidis, George</creatorcontrib><creatorcontrib>Oikonomou, Evangelos</creatorcontrib><creatorcontrib>Vrentzos, Emmanouil</creatorcontrib><creatorcontrib>Michalopoulou, Eleni</creatorcontrib><creatorcontrib>Tsigkou, Vasiliki</creatorcontrib><creatorcontrib>Katogiannis, Konstantinos</creatorcontrib><creatorcontrib>Pliouta, Loukia</creatorcontrib><creatorcontrib>Balampanis, Konstantinos</creatorcontrib><creatorcontrib>Pililis, Sotirios</creatorcontrib><creatorcontrib>Malandris, Konstantinos</creatorcontrib><creatorcontrib>Tsapas, Apostolos</creatorcontrib><creatorcontrib>Siasos, Gerasimos</creatorcontrib><creatorcontrib>Ikonomidis, Ignatios</creatorcontrib><creatorcontrib>Lambadiari, Vaia</creatorcontrib><title>Response to "Letter to Editor From Ishaq MU et al: 'Semaglutide Concurrently Improves Vascular and Liver Indices in Patients With Type 2 Diabetes and Fatty Liver Disease'"</title><title>Journal of the Endocrine Society</title><addtitle>J Endocr Soc</addtitle><subject>Letter to the Editor Response</subject><issn>2472-1972</issn><issn>2472-1972</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpVkUFv1DAQhS0EolXplSMa9VIuSzOO13a4oGrbhZUWgaCFY-SNJ11XiZ3azkr7m_iTpGJB5TRPmve9J80w9hqLd8ixuLgnb1O42OwMcdTP2DEXis-wUvz5E33ETlO6L4oCq1JUQrxkR2WlELVQx-zXN0pD8IkgBzhbU84UH-W1dTlEWMbQwyptzQN8vgXKYLr3cP6denPXjdlZgkXwzRgj-dztYdUPMewowQ-TmrEzEYy3sHa7KXTlrWumlfPw1WQ3AQl-uryFm_1AwOHKmQ3lyfCILE3O-wN45RKZROdnr9iL1nSJTg_zhN0ur28Wn2brLx9Xi8v1bEDkfDbX2lolJbZzlG0pikIoa7GxDQmhCjNvSWvDiSshuZxKK1VuJDaIVauqVpYn7MOf3GHc9DRhPkfT1UN0vYn7OhhX_7_xblvfhV2NKOV0Yj4lvD0kxPAwUsp171JDXWc8hTHVJQotKi2Enqxvnpb9a_n7ovI3gMuW0g</recordid><startdate>20241126</startdate><enddate>20241126</enddate><creator>Korakas, Emmanouil</creator><creator>Kountouri, Aikaterini</creator><creator>Pavlidis, George</creator><creator>Oikonomou, Evangelos</creator><creator>Vrentzos, Emmanouil</creator><creator>Michalopoulou, Eleni</creator><creator>Tsigkou, Vasiliki</creator><creator>Katogiannis, Konstantinos</creator><creator>Pliouta, Loukia</creator><creator>Balampanis, Konstantinos</creator><creator>Pililis, Sotirios</creator><creator>Malandris, Konstantinos</creator><creator>Tsapas, Apostolos</creator><creator>Siasos, Gerasimos</creator><creator>Ikonomidis, Ignatios</creator><creator>Lambadiari, Vaia</creator><general>Oxford University Press</general><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-2416-1461</orcidid><orcidid>https://orcid.org/0000-0003-0221-4072</orcidid><orcidid>https://orcid.org/0000-0003-4209-1871</orcidid><orcidid>https://orcid.org/0000-0001-7601-8870</orcidid><orcidid>https://orcid.org/0000-0002-5134-2401</orcidid><orcidid>https://orcid.org/0000-0001-5829-7327</orcidid><orcidid>https://orcid.org/0009-0002-2157-0814</orcidid><orcidid>https://orcid.org/0000-0001-8079-0599</orcidid><orcidid>https://orcid.org/0000-0002-7813-5488</orcidid><orcidid>https://orcid.org/0009-0007-8693-4443</orcidid><orcidid>https://orcid.org/0000-0003-1631-5210</orcidid><orcidid>https://orcid.org/0000-0002-4620-4039</orcidid><orcidid>https://orcid.org/0009-0005-6480-3878</orcidid><orcidid>https://orcid.org/0000-0001-8241-7886</orcidid></search><sort><creationdate>20241126</creationdate><title>Response to "Letter to Editor From Ishaq MU et al: 'Semaglutide Concurrently Improves Vascular and Liver Indices in Patients With Type 2 Diabetes and Fatty Liver Disease'"</title><author>Korakas, Emmanouil ; Kountouri, Aikaterini ; Pavlidis, George ; Oikonomou, Evangelos ; Vrentzos, Emmanouil ; Michalopoulou, Eleni ; Tsigkou, Vasiliki ; Katogiannis, Konstantinos ; Pliouta, Loukia ; Balampanis, Konstantinos ; Pililis, Sotirios ; Malandris, Konstantinos ; Tsapas, Apostolos ; Siasos, Gerasimos ; Ikonomidis, Ignatios ; Lambadiari, Vaia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p1122-588dd7661f516f340047dd1cdce4470a5fe88a2e274626abe973b61c119f79f63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Letter to the Editor Response</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Korakas, Emmanouil</creatorcontrib><creatorcontrib>Kountouri, Aikaterini</creatorcontrib><creatorcontrib>Pavlidis, George</creatorcontrib><creatorcontrib>Oikonomou, Evangelos</creatorcontrib><creatorcontrib>Vrentzos, Emmanouil</creatorcontrib><creatorcontrib>Michalopoulou, Eleni</creatorcontrib><creatorcontrib>Tsigkou, Vasiliki</creatorcontrib><creatorcontrib>Katogiannis, Konstantinos</creatorcontrib><creatorcontrib>Pliouta, Loukia</creatorcontrib><creatorcontrib>Balampanis, Konstantinos</creatorcontrib><creatorcontrib>Pililis, Sotirios</creatorcontrib><creatorcontrib>Malandris, Konstantinos</creatorcontrib><creatorcontrib>Tsapas, Apostolos</creatorcontrib><creatorcontrib>Siasos, Gerasimos</creatorcontrib><creatorcontrib>Ikonomidis, Ignatios</creatorcontrib><creatorcontrib>Lambadiari, Vaia</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of the Endocrine Society</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Korakas, Emmanouil</au><au>Kountouri, Aikaterini</au><au>Pavlidis, George</au><au>Oikonomou, Evangelos</au><au>Vrentzos, Emmanouil</au><au>Michalopoulou, Eleni</au><au>Tsigkou, Vasiliki</au><au>Katogiannis, Konstantinos</au><au>Pliouta, Loukia</au><au>Balampanis, Konstantinos</au><au>Pililis, Sotirios</au><au>Malandris, Konstantinos</au><au>Tsapas, Apostolos</au><au>Siasos, Gerasimos</au><au>Ikonomidis, Ignatios</au><au>Lambadiari, Vaia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Response to "Letter to Editor From Ishaq MU et al: 'Semaglutide Concurrently Improves Vascular and Liver Indices in Patients With Type 2 Diabetes and Fatty Liver Disease'"</atitle><jtitle>Journal of the Endocrine Society</jtitle><addtitle>J Endocr Soc</addtitle><date>2024-11-26</date><risdate>2024</risdate><volume>9</volume><issue>1</issue><spage>bvae218</spage><pages>bvae218-</pages><issn>2472-1972</issn><eissn>2472-1972</eissn><cop>United States</cop><pub>Oxford University Press</pub><pmid>39711847</pmid><doi>10.1210/jendso/bvae218</doi><orcidid>https://orcid.org/0000-0002-2416-1461</orcidid><orcidid>https://orcid.org/0000-0003-0221-4072</orcidid><orcidid>https://orcid.org/0000-0003-4209-1871</orcidid><orcidid>https://orcid.org/0000-0001-7601-8870</orcidid><orcidid>https://orcid.org/0000-0002-5134-2401</orcidid><orcidid>https://orcid.org/0000-0001-5829-7327</orcidid><orcidid>https://orcid.org/0009-0002-2157-0814</orcidid><orcidid>https://orcid.org/0000-0001-8079-0599</orcidid><orcidid>https://orcid.org/0000-0002-7813-5488</orcidid><orcidid>https://orcid.org/0009-0007-8693-4443</orcidid><orcidid>https://orcid.org/0000-0003-1631-5210</orcidid><orcidid>https://orcid.org/0000-0002-4620-4039</orcidid><orcidid>https://orcid.org/0009-0005-6480-3878</orcidid><orcidid>https://orcid.org/0000-0001-8241-7886</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2472-1972
ispartof Journal of the Endocrine Society, 2024-11, Vol.9 (1), p.bvae218
issn 2472-1972
2472-1972
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11663492
source DOAJ Directory of Open Access Journals; Oxford Journals Open Access Collection; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Letter to the Editor Response
title Response to "Letter to Editor From Ishaq MU et al: 'Semaglutide Concurrently Improves Vascular and Liver Indices in Patients With Type 2 Diabetes and Fatty Liver Disease'"
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T16%3A09%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Response%20to%20%22Letter%20to%20Editor%20From%20Ishaq%20MU%20et%20al:%20'Semaglutide%20Concurrently%20Improves%20Vascular%20and%20Liver%20Indices%20in%20Patients%20With%20Type%202%20Diabetes%20and%20Fatty%20Liver%20Disease'%22&rft.jtitle=Journal%20of%20the%20Endocrine%20Society&rft.au=Korakas,%20Emmanouil&rft.date=2024-11-26&rft.volume=9&rft.issue=1&rft.spage=bvae218&rft.pages=bvae218-&rft.issn=2472-1972&rft.eissn=2472-1972&rft_id=info:doi/10.1210/jendso/bvae218&rft_dat=%3Cproquest_pubme%3E3148498448%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3148498448&rft_id=info:pmid/39711847&rfr_iscdi=true